| J9271 | Injection, pembrolizumab, 1 mg | 5,600 | $40 | $240.8K |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 1,650 | $40 | $62.7K |
| J0897 | Injection, denosumab, 1 mg | 2,400 | $20 | $45.6K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 310 | $100 | $29.3K |
| 99232 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or… | 310 | $60 | $18.9K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 250 | $70 | $18.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 170 | $100 | $16.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 180 | $60 | $10.9K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 80 | $130 | $9.8K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 30 | $120 | $3K |